Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
HIV Medicine|June 7, 2026
Prior PrEP use and discontinuation in individuals newly diagnosed with HIVRohan Saini, Sarah Fidler, Marta Boffito, et al.International Journal of STD & AIDS|July 24, 2020
Does qualitative viral load testing shorten the window period for diagnosing HIV in individuals attending for post-exposure prophylaxis?Gary Whitlock, Nneka Nwokolo, HIV Medicine|March 30, 2022
Immediate PrEP when accessing PEP: A service evaluationBeatrice Cockbain, Gary Whitlock, The Clinical Teacher|January 11, 2014
Practical prescribing course: a student evaluationVicky Tittle, David Randall, Vidhya Maheswaran, et al.Cancer Causes & Control : CCC|February 22, 2012
Social inequalities, tobacco chewing, and cancer mortality in south India: a case-control analysis of 2,580 cancer deaths among non-smoking non-drinkersVendhan Gajalakshmi, Gary Whitlock, Richard PetoSeminars in Vascular Medicine|October 14, 2005
Coronary heart disease and body mass index: a systematic review of the evidence from larger prospective cohort studiesGary Whitlock, Sarah Lewington, Cliona Ni MhurchuAntiviral Therapy|September 3, 2016
Outcomes of acutely HIV-1-infected individuals following rapid antiretroviral therapy initiationNicolò Girometti, Nneka Nwokolo, Alan McOwan, et al.The New Zealand Medical Journal|November 15, 2003
Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factorsRichard Milne, Gregory Gamble, Gary Whitlock, et al.The New Zealand Medical Journal|November 15, 2003
Framingham Heart Study risk equation predicts first cardiovascular event rates in New Zealanders at the population levelRichard Milne, Gregory Gamble, Gary Whitlock, et al.Expert Opinion on Pharmacotherapy|May 23, 2015
HIV integrase inhibitors: a new era in the treatment of HIVJose Luis Blanco, Gary Whitlock, Ana Milinkovic, et al.Pageof 7